Ascentage Pharma Group Corp Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ascentage Pharma Group Corp Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10515
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascentage Pharma Group Corp Ltd (Ascentage Pharma) is a biopharmaceutical company that discovers and develops targeted small-molecule therapeutics for the treatment of cancers, hepatitis B and age-related diseases. The company’s pipeline product includes apoptosis compounds and kinase inhibitors such as APG-1387, APG-1252, APG-115, APG-2575, APG-8361, APG-1351, and APG-2449. Ascentage Pharma provides services including medicinal chemistry, analytical and formulation pharmaceutical sciences, process development, biological sciences, regulatory and compliance, preclinical studies and clinical development. The company operates through research and development centers and production facilities in Hong Kong, China, the US. Ascentage Pharma is headquartered in Pudong, China.

Ascentage Pharma Group Corp Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Ascentage Pharma Raises USD150 Million in Series C Financing 10
Ascentage Pharma Raises USD72 Million in Series B Financing 11
Ascentage Pharma Raises USD15.5 Million in Series A Financing 12
Partnerships 13
Ascentage Pharma Enters Agreement with Unity Biotechnology 13
3SBio Enters Into Strategic Alliance with Ascentage Pharma 14
Licensing Agreements 15
Ascentage Pharma Enters into Licensing Agreement with Merck 15
Ascentage Pharma Amends Licensing Agreement with Regents of the University of Michigan 16
Equity Offering 17
Ascentage Pharma Files for USD300 Million IPO 17
Ascentage Pharma Group Corp Ltd – Key Competitors 18
Ascentage Pharma Group Corp Ltd – Key Employees 19
Ascentage Pharma Group Corp Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Jan 03, 2018: Ascentage Pharma Announces Formation of Clinical Advisory Board 21
Sep 25, 2017: Ascentage Pharma: Yingjie (Jason) Huang, M.D., to Join Ascentage Pharma as Senior Vice President of Clinical Development 23
Jul 05, 2017: Ascentage Pharma Announces Appointment of Han Li as Chief Financial Officer 24
Product News 25
06/26/2017: Ascentage Announces CFDA Grants Bcl-2/Bcl-XL inhibitor APG-1252 IND Approval for Treatment of Cancers 25
Product Approvals 26
Jan 08, 2018: Ascentage Pharma Announces Acceptance of IND Application by China FDA for Clinical Study of Novel IAP Inhibitor to Treat Hepatitis B Infection 26
Nov 15, 2017: Ascentage Pharma Announces U.S. FDA Acceptance of IND Application for Clinical Study of Novel IAP Inhibitor APG-1387 to Treat Advanced Solid Tumors and Blood Cancers 27
Clinical Trials 28
May 21, 2018: Ascentage Pharma Announces Promising Phase 1 Interim Results Of APG-1252 At 2018 ASCO Annual Meeting 28
May 21, 2018: Ascentage Pharma Announces Promising Phase 1 Interim Results Of APG-1387 At 2018 ASCO Annual Meeting 29
Feb 21, 2018: Ascentage Pharma to Present at the IASLC 18th Lung Cancer Targeted Therapies Meeting 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascentage Pharma Group Corp Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ascentage Pharma Raises USD150 Million in Series C Financing 10
Ascentage Pharma Raises USD72 Million in Series B Financing 11
Ascentage Pharma Raises USD15.5 Million in Series A Financing 12
Ascentage Pharma Enters Agreement with Unity Biotechnology 13
3SBio Enters Into Strategic Alliance with Ascentage Pharma 14
Ascentage Pharma Enters into Licensing Agreement with Merck 15
Ascentage Pharma Amends Licensing Agreement with Regents of the University of Michigan 16
Ascentage Pharma Files for USD300 Million IPO 17
Ascentage Pharma Group Corp Ltd, Key Competitors 18
Ascentage Pharma Group Corp Ltd, Key Employees 19
Ascentage Pharma Group Corp Ltd, Other Locations 20

List of Figures
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascentage Pharma Group Corp Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ascentage Pharma Group Corp Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inter Parfums SA:企業の戦略・SWOT・財務情報
    Inter Parfums SA - Strategy, SWOT and Corporate Finance Report Summary Inter Parfums SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Altice Europe Nv
    Altice Europe Nv - Strategy, SWOT and Corporate Finance Report Summary Altice Europe Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops gene expression platform for production of industrial enzymes and other proteins. The company utilizes C1 technology, an expression system based on the fungus Myceliophthora thermophila, to discover and manufacture bi …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Imperial Oil Ltd (IMO):企業の財務・戦略的SWOT分析
    Imperial Oil Ltd (IMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Invenergy LLC:発電所・企業SWOT分析
    Invenergy LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Forestar Group Inc:企業の戦略・SWOT・財務情報
    Forestar Group Inc - Strategy, SWOT and Corporate Finance Report Summary Forestar Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medicago Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline …
  • Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • Belfius Bank SA:企業の戦略・SWOT・財務情報
    Belfius Bank SA - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CPC Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary CPC Corp (CPC) is an integrated oil and gas company. The company explores for, develops, and produces oil and natural gas from its assets in Taiwan, Ecuador, Indonesia, Niger, Chad, Australia, the US, and Congo. CPC operates refinery and petrochemical complexes in Taoyuan and Dalin. The comp …
  • Chorus Aviation Inc.:戦略・SWOT・企業財務分析
    Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report Summary Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ralph Lauren Corporation:戦略・SWOT・企業財務分析
    Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aushon BioSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira servic …
  • Sonic Corp.:企業の戦略・SWOT・財務情報
    Sonic Corp. - Strategy, SWOT and Corporate Finance Report Summary Sonic Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Polpharma SA:企業の戦略的SWOT分析
    Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Toll Holdings Ltd:企業の戦略的SWOT分析
    Toll Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Oando Plc (OANDO):石油・ガス:M&Aディール及び事業提携情報
    Summary Oando Plc (Oando) is a provider of integrated energy solutions to the oil and gas industry. Through its subsidiaries, the company explores for and produces oil and gas through the acquisition of rights in oil blocks on the Nigerian continental shelf and deep offshore. It has producing, devel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆